Robotic single site versus robotic multiport hysterectomy in early endometrial cancer: a case control study.
- Author:
Giacomo CORRADO
1
;
Giuseppe CUTILLO
;
Emanuela MANCINI
;
Ermelinda BAIOCCO
;
Lodovico PATRIZI
;
Maria SALTARI
;
Anna DI LUCA SIDOZZI
;
Isabella SPERDUTI
;
Giulia POMATI
;
Enrico VIZZA
Author Information
- Publication Type:Original Article
- Keywords: Endometrial Neoplasms; Minimally Invasive Surgical Procedures; Robotic Hysterectomy; Robotic Single Site Hysterectomy
- MeSH: Adult; Aged; Aged, 80 and over; Case-Control Studies; Endometrial Neoplasms/economics/*surgery; Female; Health Care Costs; Humans; Hysterectomy/adverse effects/*methods; Middle Aged; Postoperative Complications/epidemiology; Retrospective Studies; Robotic Surgical Procedures/adverse effects/economics/*methods
- From:Journal of Gynecologic Oncology 2016;27(4):e39-
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: To compare surgical outcomes and cost of robotic single-site hysterectomy (RSSH) versus robotic multiport hysterectomy (RMPH) in early stage endometrial cancer. METHODS: This is a retrospective case-control study, comparing perioperative outcomes and costs of RSSH and RMPH in early stage endometrial cancer patients. RSSH were matched 1:2 according to age, body mass index, comorbidity, the International Federation of Gynecology and Obstetric (FIGO) stage, type of radical surgery, histologic type, and grading. Mean hospital cost per discharge was calculated summarizing the cost of daily hospital room charges, operating room, cost of supplies and length of hospital stay. RESULTS: A total of 23 women who underwent RSSH were matched with 46 historic controls treated by RMPH in the same institute, with the same surgical team. No significant differences were found in terms of age, histologic type, stage, and grading. Operative time was similar: 102.5 minutes in RMPH and 110 in RSSH (p=0.889). Blood loss was lower in RSSH than in RMPH (respectively, 50 mL vs. 100 mL, p=0.001). Hospital stay was 3 days in RMPH and 2 days in RSSH (p=0.001). No intraoperative complications occurred in both groups. Early postoperative complications were 2.2% in RMPH and 4.3% in RSSH. Overall cost was higher in RMPH than in RSSH (respectively, $7,772.15 vs. $5,181.06). CONCLUSION: Our retrospective study suggests the safety and feasibility of RSSH for staging early endometrial cancer without major differences from the RMPH in terms of surgical outcomes, but with lower hospital costs. Certainly, further studies are eagerly warranted to confirm our findings.
